Human fibroblasts from patients (Sainio et al., 2018 (link)) and healthy controls (Trokovic et al., 2015 (link)) were reprogrammed into pluripotent stem cells with overexpression of MYC, KLF4, SOX2, and OCT4 by the Biomedicum Stem Cell Center (University of Helsinki, Finland) as in Trokovic et al. (2015 (link)). Stem cells were grown in feeder-free conditions with Matrigel (Corning) and E8 with E8 supplement (Gibco) in normoxia at 37°C. At 90% confluency, cells were passaged with 0.5 mM EDTA (Invitrogen) in PBS.
Free full text: Click here